Hannelore Schmidt

1.5k total citations
53 papers, 1.2k citations indexed

About

Hannelore Schmidt is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Hannelore Schmidt has authored 53 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Hannelore Schmidt's work include Sarcoma Diagnosis and Treatment (24 papers), Cancer-related Molecular Pathways (19 papers) and Cancer Research and Treatments (7 papers). Hannelore Schmidt is often cited by papers focused on Sarcoma Diagnosis and Treatment (24 papers), Cancer-related Molecular Pathways (19 papers) and Cancer Research and Treatments (7 papers). Hannelore Schmidt collaborates with scholars based in Germany, United States and Canada. Hannelore Schmidt's co-authors include Helge Täubert, Matthias Bache, Axel Meye, Frank Bartel, Peter Würl, Matthias Kappler, Karen Blümke, Christine Lautenschläger, Hans-Jürgen Holzhausen and Raoul Hinze and has published in prestigious journals such as Cancer, Oncogene and Journal of Medicinal Chemistry.

In The Last Decade

Hannelore Schmidt

52 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hannelore Schmidt Germany 20 619 490 396 176 110 53 1.2k
Jinyoung Yoo South Korea 20 458 0.7× 324 0.7× 334 0.8× 112 0.6× 62 0.6× 64 1.1k
S. Bretti Italy 13 449 0.7× 391 0.8× 233 0.6× 104 0.6× 124 1.1× 33 1.3k
Sajida Piperdi United States 17 410 0.7× 521 1.1× 464 1.2× 222 1.3× 94 0.9× 25 1.1k
Ioannis Diamantis Switzerland 20 374 0.6× 240 0.5× 154 0.4× 147 0.8× 104 0.9× 48 1.2k
Hirohisa Hirabayashi Japan 13 339 0.5× 462 0.9× 219 0.6× 127 0.7× 93 0.8× 28 979
Yasuji Ishimaru Japan 14 346 0.6× 241 0.5× 204 0.5× 222 1.3× 171 1.6× 45 1.1k
Carmen Nuzzo Italy 14 403 0.7× 481 1.0× 312 0.8× 189 1.1× 30 0.3× 31 1.0k
Hideya Takeuchi Japan 17 371 0.6× 584 1.2× 358 0.9× 225 1.3× 42 0.4× 70 1.3k
Hideaki Kakinuma Japan 18 658 1.1× 321 0.7× 233 0.6× 182 1.0× 21 0.2× 34 1.1k
Y Oshika Japan 23 996 1.6× 745 1.5× 319 0.8× 436 2.5× 25 0.2× 50 1.7k

Countries citing papers authored by Hannelore Schmidt

Since Specialization
Citations

This map shows the geographic impact of Hannelore Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannelore Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannelore Schmidt more than expected).

Fields of papers citing papers by Hannelore Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannelore Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannelore Schmidt. The network helps show where Hannelore Schmidt may publish in the future.

Co-authorship network of co-authors of Hannelore Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Hannelore Schmidt. A scholar is included among the top collaborators of Hannelore Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannelore Schmidt. Hannelore Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jentsch, Holger, et al.. (2008). Gingival crevicular fluid levels of aspartate aminotransferase and alpha2-macroglobulin before and after topical application of metronidazole or scaling and root planing. Quintessence International. 39(5). 381–389. 7 indexed citations
2.
Täubert, Helge, Matthias Kappler, Matthias Bache, et al.. (2005). Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients. Oncogene. 24(33). 5258–5261. 32 indexed citations
3.
Kappler, Matthias, Matthias Bache, Frank Bartel, et al.. (2004). Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53. Cancer Gene Therapy. 11(3). 186–193. 99 indexed citations
4.
Täubert, Helge, Frank Bartel, Matthias Kappler, et al.. (2003). Reduced expression of hMSH2 protein is correlated to poor survival for soft tissue sarcoma patients. Cancer. 97(9). 2273–2278. 16 indexed citations
5.
Täubert, Helge, Katja Schuster, Ulrich Brinck, et al.. (2003). Loss of Heterozygosity at 12q14-15 Often Occurs in Stage I Soft Tissue Sarcomas and Is Associated with MDM2 Amplification in Tumors at Various Stages. Modern Pathology. 16(11). 1109–1116. 8 indexed citations
6.
Krüger, Stefan, et al.. (2002). Fibrosarcoma Associated with a Benign Cystic Teratoma of the Ovary. Gynecologic Oncology. 84(1). 150–154. 16 indexed citations
7.
Bartel, Frank, Axel Meye, Matthias Kappler, et al.. (2001). Amplification of themdm2 gene, but not expression of splice variants ofmdm2 mrna, is associated with prognosis in soft tissue sarcoma. International Journal of Cancer. 95(3). 168–175. 72 indexed citations
8.
Kappler, Matthias, Marc Schmitz, Frank Bartel, et al.. (2001). Increased survivin transcript levels: An independent negative predictor of survival in soft tissue sarcoma patients. International Journal of Cancer. 95(6). 360–363. 78 indexed citations
9.
Täubert, Helge, Matthias Kappler, Axel Meye, et al.. (2000). A MboII polymorphism in exon 11 of the human MDM2 gene occuring in normal blood donors and in soft tissue sarcoma patients: an indication for an increased cancer susceptibility?. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 456(1-2). 39–44. 4 indexed citations
10.
Meye, Axel, Peter Würl, Matthias Bache, et al.. (2000). Colony formation of soft tissue sarcoma cells is inhibited by lipid-mediated antisense oligodeoxynucleotides targeting the human mdm2 oncogene. Cancer Letters. 149(1-2). 181–188. 11 indexed citations
11.
Schmidt, Hannelore, Helge Täubert, Axel Meye, et al.. (2000). Gains in chromosomes 7, 8q, 15q and 17q are characteristic changes in malignant but not in benign peripheral nerve sheath tumors from patients with Recklinghausen's disease. Cancer Letters. 155(2). 181–190. 51 indexed citations
12.
Würl, Peter, Axel Meye, Christine Lautenschläger, et al.. (1999). Clinical relevance of pRb and p53 Co-overexpression in soft tissue sarcomas. Cancer Letters. 139(2). 159–165. 11 indexed citations
13.
Meye, Axel, Peter Würl, Raoul Hinze, et al.. (1998). No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas. The Journal of Pathology. 184(1). 14–17. 13 indexed citations
14.
Würl, Peter, Axel Meye, Dieter Berger, et al.. (1998). Significance of retinoblastoma and mdm2 gene expression as prognostic markers for soft-tissue sarcoma. Langenbeck s Archives of Surgery. 383(1). 99–103. 17 indexed citations
15.
Täubert, Helge, Dieter Berger, Raoul Hinze, et al.. (1998). How is the mutational status for tumor suppressors p53 and p16INK4A in MFH of the bone?. Cancer Letters. 123(2). 147–151. 6 indexed citations
16.
Täubert, Helge, Axel Meye, Matthias Bache, et al.. (1998). p53 status in radiation-induced soft-tissue sarcomas. Strahlentherapie und Onkologie. 174(8). 427–430. 4 indexed citations
17.
Moll, Ingrid, Pia Houdek, Hannelore Schmidt, & Roland Moll. (1998). Characterization of Epidermal Wound Healing in a Human Skin Organ Culture Model: Acceleration by Transplanted Keratinocytes1. Journal of Investigative Dermatology. 111(2). 251–258. 63 indexed citations
18.
Schmidt, Hannelore, Raoul Hinze, Helge Täubert, et al.. (1998). Cytogenetic Characterization of Ten Malignant Fibrous Histiocytomas. Cancer Genetics and Cytogenetics. 100(2). 134–142. 14 indexed citations
19.
Schmelz, Martin, Dennis Way, Wiebke K. Peitsch, et al.. (1998). A novel type of adhering junction in an epithelioid tumorigenic rat cell culture line. Cell and Tissue Research. 294(1). 11–25. 10 indexed citations
20.
Würl, Peter, Helge Täubert, Matthias Bache, et al.. (1996). Frequent occurrence of p53 mutations in rhabdomyosarcoma and leiomyosarcoma, but not in fibrosarcoma and malignant neural tumors. International Journal of Cancer. 69(4). 317–323. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinyoung Yoo Breakdown of academic impact, for papers by S. Bretti Breakdown of academic impact, for papers by Sajida Piperdi Breakdown of academic impact, for papers by Ioannis Diamantis Breakdown of academic impact, for papers by Hirohisa Hirabayashi Breakdown of academic impact, for papers by Yasuji Ishimaru Breakdown of academic impact, for papers by Carmen Nuzzo Breakdown of academic impact, for papers by Hideya Takeuchi Breakdown of academic impact, for papers by Hideaki Kakinuma Breakdown of academic impact, for papers by Y Oshika
Rankless by CCL
2026